- Investing Ideas
- /
- U.S. High Insider Buying
U.S. High Insider Buying
Results
502
0 new
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
502 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GLBZ | US$4.85 | 3.9% | -26.0% | US$13.9m | n/a | PB0.8x | n/a | 0% | Banks | ||
BBGI | US$7.84 | -3.4% | -53.5% | US$13.7m | n/a | PE5.4x | n/a | 0% | Media | ||
ACXP | US$0.76 | 3.9% | -74.6% | US$13.1m | US$11.19 | PB4.8x | E25.7% | n/a | Pharmaceuticals & Biotech | ||
OMEX | US$0.47 | -7.2% | -89.0% | US$12.9m | n/a | PE1.1x | n/a | n/a | Commercial Services | ||
MRAI | US$1.00 | 12.4% | -23.7% | US$12.6m | n/a | PS0.5x | n/a | n/a | Insurance | ||
BLTH.D | US$5.95 | -0.7% | 197.5% | US$11.9m | n/a | PE-7.2x | n/a | n/a | Materials | ||
BETR.F | US$0.084 | -3.9% | 15.9% | US$11.7m | n/a | PE-3.8x | n/a | n/a | Pharmaceuticals & Biotech | ||
BLMH | US$1.19 | -0.5% | 40.4% | US$11.4m | n/a | PS0.3x | n/a | n/a | Consumer Retailing | ||
DLPN | US$1.02 | -3.8% | -65.3% | US$11.4m | US$5.00 | PS0.2x | E110.6% | n/a | Media | ||
GUER | US$1.04 | -11.1% | -75.8% | US$11.1m | n/a | PS0.5x | n/a | n/a | Semiconductors | ||
SCKT | US$1.41 | -2.1% | 31.8% | US$10.8m | n/a | PS0.6x | n/a | n/a | Tech | ||
ZONE | US$1.19 | 16.7% | n/a | US$10.7m | n/a | PS6x | n/a | n/a | Capital Goods | ||
YHC | US$0.86 | -21.8% | -62.6% | US$10.6m | US$5.00 | PS4.7x | E17.5% | n/a | Media | ||
BSLK | US$0.32 | 10.0% | -97.0% | US$10.5m | n/a | PE0.07x | n/a | n/a | Materials | ||
KITT | US$1.74 | 8.8% | -83.9% | US$10.4m | n/a | PS4.6x | n/a | n/a | Capital Goods | ||
AEI | US$0.95 | 7.6% | -14.1% | US$10.2m | n/a | PS0.8x | n/a | n/a | Real Estate Management and Development | ||
BMNM | US$1.00 | 0% | n/a | US$10.0m | n/a | PS0.8x | n/a | n/a | Diversified Financials | ||
UBXG | US$2.85 | -10.7% | n/a | US$9.9m | n/a | PS0.2x | n/a | n/a | Software | ||
LMFA | US$1.88 | 2.7% | -37.5% | US$9.9m | US$6.00 | PS0.8x | E-17.9% | n/a | Software | ||
GIPR | US$1.71 | -1.4% | -52.9% | US$9.4m | n/a | PB1.5x | E15.3% | 0% | Real Estate | ||
AMST | US$3.28 | -4.9% | 35.0% | US$9.0m | n/a | PS106.4x | n/a | n/a | Consumer Services | ||
ICU | US$1.80 | -21.1% | -92.0% | US$8.7m | US$7.00 | PS118.1x | E24.2% | n/a | Healthcare | ||
MYCB | US$0.67 | -32.1% | 180.1% | US$8.6m | n/a | PE269.5x | n/a | n/a | Real Estate Management and Development | ||
SQFT | US$0.63 | -6.8% | -37.9% | US$8.3m | n/a | PB0.3x | n/a | 0% | Real Estate |